Literature DB >> 24951239

The placebo effect in asthma.

Stefanie Dutile1, Ted J Kaptchuk, Michael E Wechsler.   

Abstract

The placebo effect is a complex phenomenon occurring across a variety of clinical conditions. While much placebo research has been conducted in diseases defined by self-report such as depression, chronic pain, and irritable bowel syndrome (IBS), asthma has been proposed as a useful model because of its easily measured objective outcomes. Studies examining the placebo response in asthma have not only contributed to an understanding of the mechanisms behind the placebo response but also shed an interesting light on the current treatment and diagnosis of asthma. This paper will review current literature on placebos in general and specifically on the placebo response in asthma. It focuses on what we know about the mechanisms behind the placebo effect, whether there is a specific portion of the population who responds to placebos, which patient outcomes are influenced by the placebo effect, and whether the effect can be augmented.

Entities:  

Mesh:

Year:  2014        PMID: 24951239      PMCID: PMC4351653          DOI: 10.1007/s11882-014-0456-2

Source DB:  PubMed          Journal:  Curr Allergy Asthma Rep        ISSN: 1529-7322            Impact factor:   4.806


  52 in total

1.  Lessons from recent research about the placebo effect--from art to science.

Authors:  Howard Brody; Franklin G Miller
Journal:  JAMA       Date:  2011-12-21       Impact factor: 56.272

Review 2.  A comprehensive review of the placebo effect: recent advances and current thought.

Authors:  Donald D Price; Damien G Finniss; Fabrizio Benedetti
Journal:  Annu Rev Psychol       Date:  2008       Impact factor: 24.137

3.  Introduction to placebo effects in medicine: mechanisms and clinical implications.

Authors:  Karin Meissner; Niko Kohls; Luana Colloca
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2011-06-27       Impact factor: 6.237

4.  When are clinical trials of a given agent vs. placebo no longer appropriate or feasible?

Authors:  R J Temple
Journal:  Control Clin Trials       Date:  1997-12

5.  Influences of suggestion on airway reactivity in asthmatic subjects.

Authors:  T Luparello; H A Lyons; E R Bleecker; E R McFadden
Journal:  Psychosom Med       Date:  1968 Nov-Dec       Impact factor: 4.312

6.  Placebo response in asthma: a robust and objective phenomenon.

Authors:  Margaret E Kemeny; Lanny J Rosenwasser; Reynold A Panettieri; Robert M Rose; Steve M Berg-Smith; Joel N Kline
Journal:  J Allergy Clin Immunol       Date:  2007-04-23       Impact factor: 10.793

7.  Behavioral conditioning of antihistamine effects in patients with allergic rhinitis.

Authors:  Marion U Goebel; Nuschin Meykadeh; Wei Kou; Manfred Schedlowski; Ulrich R Hengge
Journal:  Psychother Psychosom       Date:  2008-04-16       Impact factor: 17.659

8.  Effectiveness and safety of bronchial thermoplasty in the treatment of severe asthma: a multicenter, randomized, double-blind, sham-controlled clinical trial.

Authors:  Mario Castro; Adalberto S Rubin; Michel Laviolette; Jussara Fiterman; Marina De Andrade Lima; Pallav L Shah; Elie Fiss; Ronald Olivenstein; Neil C Thomson; Robert M Niven; Ian D Pavord; Michael Simoff; David R Duhamel; Charlene McEvoy; Richard Barbers; Nicolaas H T Ten Hacken; Michael E Wechsler; Mark Holmes; Martin J Phillips; Serpil Erzurum; William Lunn; Elliot Israel; Nizar Jarjour; Monica Kraft; Narinder S Shargill; John Quiring; Scott M Berry; Gerard Cox
Journal:  Am J Respir Crit Care Med       Date:  2009-10-08       Impact factor: 21.405

9.  Placebos without deception: a randomized controlled trial in irritable bowel syndrome.

Authors:  Ted J Kaptchuk; Elizabeth Friedlander; John M Kelley; M Norma Sanchez; Efi Kokkotou; Joyce P Singer; Magda Kowalczykowski; Franklin G Miller; Irving Kirsch; Anthony J Lembo
Journal:  PLoS One       Date:  2010-12-22       Impact factor: 3.240

10.  Randomised controlled trials may underestimate drug effects: balanced placebo trial design.

Authors:  Karen Lund; Lene Vase; Gitte L Petersen; Troels S Jensen; Nanna B Finnerup
Journal:  PLoS One       Date:  2014-01-08       Impact factor: 3.240

View more
  13 in total

1.  Bronchial Thermoplasty Including the Middle Lobe Bronchus Significantly Improves Lung Function and Quality of Life in Patients Suffering from Severe Asthma.

Authors:  Stephan Eisenmann; Wolfgang Schütte; Faustina Funke; Filiz Oezkan; Shaheen Islam; Kaid Darwiche
Journal:  Lung       Date:  2019-05-27       Impact factor: 2.584

2.  Pharmacogenomics and Placebo Response in a Randomized Clinical Trial in Asthma.

Authors:  Rui-Sheng Wang; Damien C Croteau-Chonka; Edwin K Silverman; J Loscalzo; Scott T Weiss; Kathryn T Hall
Journal:  Clin Pharmacol Ther       Date:  2019-10-28       Impact factor: 6.875

Review 3.  The placebo response of injectable GLP-1 receptor agonists vs. oral DPP-4 inhibitors and SGLT-2 inhibitors: a systematic review and meta-analysis.

Authors:  Helena M de Wit; Maarten Te Groen; Maroeska M Rovers; Cees J Tack
Journal:  Br J Clin Pharmacol       Date:  2016-04-22       Impact factor: 4.335

4.  The precision interventions for severe and/or exacerbation-prone asthma (PrecISE) adaptive platform trial: statistical considerations.

Authors:  Anastasia Ivanova; Elliot Israel; Lisa M LaVange; Michael C Peters; Loren C Denlinger; Wendy C Moore; Leonard B Bacharier; M Alison Marquis; Nathan M Gotman; Michael R Kosorok; Chalmer Tomlinson; David T Mauger; Steve N Georas; Rosalind J Wright; Patricia Noel; Gary L Rosner; Praveen Akuthota; Dean Billheimer; Eugene R Bleecker; Juan Carlos Cardet; Mario Castro; Emily A DiMango; Serpil C Erzurum; John V Fahy; Merritt L Fajt; Benjamin M Gaston; Fernando Holguin; Sonia Jain; Nicholas J Kenyon; Jerry A Krishnan; Monica Kraft; Rajesh Kumar; Mark C Liu; Ngoc P Ly; James N Moy; Wanda Phipatanakul; Kristie Ross; Lewis J Smith; Stanley J Szefler; W Gerald Teague; Michael E Wechsler; Sally E Wenzel; Steven R White
Journal:  J Biopharm Stat       Date:  2020-09-17       Impact factor: 1.051

5.  Daily patient-reported health status assessment improvements with benralizumab for patients with severe, uncontrolled eosinophilic asthma.

Authors:  Sean O'Quinn; Xiao Xu; Ian Hirsch
Journal:  J Asthma Allergy       Date:  2019-01-23

6.  Evaluation of the placebo effect in the trials of allergen immunotherapy effectiveness: meta-analysis of randomized and placebo-controlled trials.

Authors:  Michał Abramowicz; Jerzy Kruszewski; Andrzej Chciałowski
Journal:  Postepy Dermatol Alergol       Date:  2018-11-13       Impact factor: 1.837

7.  Bimodal Release Ondansetron for Acute Gastroenteritis Among Adolescents and Adults: A Randomized Clinical Trial.

Authors:  Robert A Silverman; Stacey L House; Andrew C Meltzer; Barry Hahn; Luis M Lovato; Jahn Avarello; Joseph B Miller; Ira N Kalfus; Reza Fathi; Gilead Raday; Terry F Plasse; Eric C Yan
Journal:  JAMA Netw Open       Date:  2019-11-01

8.  Relationship Between Benralizumab Exposure and Efficacy for Patients With Severe Eosinophilic Asthma.

Authors:  Yen Lin Chia; Li Yan; Binbing Yu; Bing Wang; Peter Barker; Mitchell Goldman; Lorin Roskos
Journal:  Clin Pharmacol Ther       Date:  2019-03-22       Impact factor: 6.875

Review 9.  [Recommendations for use of topical inhalant budesonide in COVID-19 : A position paper of the German Society for Applied Allergology (AeDA) and the German Society of Oto-Rhino-Laryngology, Head and Neck Surgery (DGHNO). German version].

Authors:  Ludger Klimek; Roland Buhl; Thomas Deitmer; Stefan Plontke; Wolfgang Wehrmann; Hans Merk; Johannes Ring; Sven Becker
Journal:  HNO       Date:  2021-06-17       Impact factor: 1.284

Review 10.  Recommendations for use of topical inhalant budesonide in COVID-19 : A Position Paper of the German Society for Applied Allergology (AeDA) and the German Society of Oto-Rhino-Laryngology, Head and Neck Surgery (DGHNO).

Authors:  Ludger Klimek; Roland Buhl; Thomas Deitmer; Stefan Plontke; Wolfgang Wehrmann; Hans Merk; Johannes Ring; Sven Becker
Journal:  HNO       Date:  2021-07-16       Impact factor: 1.284

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.